[Diuretic effect of spironolactone (Sc-9420) in patients with cirrhosis of the liver with ascites]. 1961

A RIVERA, and B SEPULVEDA, and L LANDA, and L CHAGOYA

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D000451 Mineralocorticoid Receptor Antagonists Drugs that bind to and block the activation of MINERALOCORTICOID RECEPTORS by MINERALOCORTICOIDS such as ALDOSTERONE. Aldosterone Antagonist,Aldosterone Antagonists,Aldosterone Receptor Antagonist,Mineralocorticoid Antagonist,Mineralocorticoid Receptor Antagonist,Aldosterone Receptor Antagonists,Mineralocorticoid Antagonists,Antagonist, Aldosterone,Antagonist, Aldosterone Receptor,Antagonist, Mineralocorticoid,Antagonist, Mineralocorticoid Receptor,Antagonists, Aldosterone,Antagonists, Aldosterone Receptor,Antagonists, Mineralocorticoid,Antagonists, Mineralocorticoid Receptor,Receptor Antagonist, Aldosterone,Receptor Antagonist, Mineralocorticoid,Receptor Antagonists, Aldosterone,Receptor Antagonists, Mineralocorticoid
D001201 Ascites Accumulation or retention of free fluid within the peritoneal cavity.
D013148 Spironolactone A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827) Spirolactone,Aldactone,Aldactone A,Aquareduct,Duraspiron,Espironolactona Alter,Espironolactona Mundogen,Flumach,Frumikal,Jenaspiron,Novo-Spiroton,Practon,SC-9420,Spiractin,Spiro L.U.T.,Spiro Von Ct,Spirobeta,Spirogamma,Spirolang,Spirono-Isis,Spironone,Spirospare,Veroshpiron,Verospiron,Verospirone,Ct, Spiro Von,Novo Spiroton,NovoSpiroton,SC 9420,SC9420,Spirono Isis,Von Ct, Spiro

Related Publications

A RIVERA, and B SEPULVEDA, and L LANDA, and L CHAGOYA
December 1959, Revista medica de Chile,
A RIVERA, and B SEPULVEDA, and L LANDA, and L CHAGOYA
March 1962, The Tohoku journal of experimental medicine,
A RIVERA, and B SEPULVEDA, and L LANDA, and L CHAGOYA
February 1960, Lancet (London, England),
A RIVERA, and B SEPULVEDA, and L LANDA, and L CHAGOYA
January 1986, Journal of hepatology,
A RIVERA, and B SEPULVEDA, and L LANDA, and L CHAGOYA
July 1960, Giornale di clinica medica,
A RIVERA, and B SEPULVEDA, and L LANDA, and L CHAGOYA
January 1993, Journal of cardiovascular pharmacology,
A RIVERA, and B SEPULVEDA, and L LANDA, and L CHAGOYA
January 1972, The Journal of clinical pharmacology and new drugs,
A RIVERA, and B SEPULVEDA, and L LANDA, and L CHAGOYA
November 1970, British medical journal,
A RIVERA, and B SEPULVEDA, and L LANDA, and L CHAGOYA
September 1965, Revista medica de Chile,
Copied contents to your clipboard!